Glaucoma Treatment Industry Research Report 2023

Glaucoma Treatment Industry Research Report 2023


Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

Highlights

The global Glaucoma Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the Hong Kong market, the main Glaucoma Treatment players include Novartis, Allergan, Pfizer, Akorn, etc. The top four Glaucoma Treatment players account for approximately 60% of the total global market. In terms of Product, Prostaglandin Analogs (PGAs) is the largest segment with a share of 52%. And in terms of Applications, the largest segment is Clinic, followed by Pharmacy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glaucoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Treatment.
The Glaucoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glaucoma Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glaucoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma

Product Type Insights

Global markets are presented by Glaucoma Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Glaucoma Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Glaucoma Treatment segment by Product
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Glaucoma Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Glaucoma Treatment market.
Glaucoma Treatment Segment by Application

Clinic
Pharmacy
Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Glaucoma Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glaucoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Glaucoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Glaucoma Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glaucoma Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Glaucoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Glaucoma Treatment by Product
2.2.1 Market Value Comparison by Product (2018 VS 2022 VS 2029)
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Beta Blocker
1.2.4 Alpha Agonist
1.2.5 Others
2.3 Glaucoma Treatment by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Other
2.4 Assumptions and Limitations
3 Glaucoma Treatment Breakdown Data by Product
3.1 Global Glaucoma Treatment Historic Market Size by Product (2018-2023)
3.2 Global Glaucoma Treatment Forecasted Market Size by Product (2023-2028)
4 Glaucoma Treatment Breakdown Data by Application
4.1 Global Glaucoma Treatment Historic Market Size by Application (2018-2023)
4.2 Global Glaucoma Treatment Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Glaucoma Treatment Market Perspective (2018-2029)
5.2 Global Glaucoma Treatment Growth Trends by Region
5.2.1 Global Glaucoma Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Glaucoma Treatment Historic Market Size by Region (2018-2023)
5.2.3 Glaucoma Treatment Forecasted Market Size by Region (2024-2029)
5.3 Glaucoma Treatment Market Dynamics
5.3.1 Glaucoma Treatment Industry Trends
5.3.2 Glaucoma Treatment Market Drivers
5.3.3 Glaucoma Treatment Market Challenges
5.3.4 Glaucoma Treatment Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Glaucoma Treatment Players by Revenue
6.1.1 Global Top Glaucoma Treatment Players by Revenue (2018-2023)
6.1.2 Global Glaucoma Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Glaucoma Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Glaucoma Treatment Head office and Area Served
6.4 Global Glaucoma Treatment Players, Product Type & Application
6.5 Global Glaucoma Treatment Players, Date of Enter into This Industry
6.6 Global Glaucoma Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Glaucoma Treatment Market Size (2018-2029)
7.2 North America Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Glaucoma Treatment Market Size by Country (2018-2023)
7.4 North America Glaucoma Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Glaucoma Treatment Market Size (2018-2029)
8.2 Europe Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Glaucoma Treatment Market Size by Country (2018-2023)
8.4 Europe Glaucoma Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Glaucoma Treatment Market Size (2018-2029)
9.2 Asia-Pacific Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Glaucoma Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Glaucoma Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Glaucoma Treatment Market Size (2018-2029)
10.2 Latin America Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Glaucoma Treatment Market Size by Country (2018-2023)
10.4 Latin America Glaucoma Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Glaucoma Treatment Market Size (2018-2029)
11.2 Middle East & Africa Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Glaucoma Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Glaucoma Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Glaucoma Treatment Introduction
11.1.4 Novartis Revenue in Glaucoma Treatment Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Glaucoma Treatment Introduction
11.2.4 Allergan Revenue in Glaucoma Treatment Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Glaucoma Treatment Introduction
11.3.4 Pfizer Revenue in Glaucoma Treatment Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Akorn
11.4.1 Akorn Company Detail
11.4.2 Akorn Business Overview
11.4.3 Akorn Glaucoma Treatment Introduction
11.4.4 Akorn Revenue in Glaucoma Treatment Business (2017-2022)
11.4.5 Akorn Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Glaucoma Treatment Introduction
11.5.4 Teva Revenue in Glaucoma Treatment Business (2017-2022)
11.5.5 Teva Recent Development
11.6 Bausch & Lomb
11.6.1 Bausch & Lomb Company Detail
11.6.2 Bausch & Lomb Business Overview
11.6.3 Bausch & Lomb Glaucoma Treatment Introduction
11.6.4 Bausch & Lomb Revenue in Glaucoma Treatment Business (2017-2022)
11.6.5 Bausch & Lomb Recent Development
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Detail
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Glaucoma Treatment Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2017-2022)
11.7.5 Otsuka Pharmaceutical Recent Development
11.8 Santen
11.8.1 Santen Company Detail
11.8.2 Santen Business Overview
11.8.3 Santen Glaucoma Treatment Introduction
11.8.4 Santen Revenue in Glaucoma Treatment Business (2017-2022)
11.8.5 Santen Recent Development
11.9 Lunan Pharma
11.9.1 Lunan Pharma Company Detail
11.9.2 Lunan Pharma Business Overview
11.9.3 Lunan Pharma Glaucoma Treatment Introduction
11.9.4 Lunan Pharma Revenue in Glaucoma Treatment Business (2017-2022)
11.9.5 Lunan Pharma Recent Development
11.10 Zizhu Pharma
11.10.1 Zizhu Pharma Company Detail
11.10.2 Zizhu Pharma Business Overview
11.10.3 Zizhu Pharma Glaucoma Treatment Introduction
11.10.4 Zizhu Pharma Revenue in Glaucoma Treatment Business (2017-2022)
11.10.5 Zizhu Pharma Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Product (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Glaucoma Treatment Market Size by Product (2018-2023) & (US$ Million)
Table 6. Global Glaucoma Treatment Revenue Market Share by Product (2018-2023)
Table 7. Global Glaucoma Treatment Forecasted Market Size by Product (2024-2029) & (US$ Million)
Table 8. Global Glaucoma Treatment Revenue Market Share by Product (2024-2029)
Table 9. Global Glaucoma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Glaucoma Treatment Revenue Market Share by Application (2018-2023)
Table 11. Global Glaucoma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Glaucoma Treatment Revenue Market Share by Application (2024-2029)
Table 13. Global Glaucoma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Glaucoma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Glaucoma Treatment Market Share by Region (2018-2023)
Table 16. Global Glaucoma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Glaucoma Treatment Market Share by Region (2024-2029)
Table 18. Glaucoma Treatment Market Trends
Table 19. Glaucoma Treatment Market Drivers
Table 20. Glaucoma Treatment Market Challenges
Table 21. Glaucoma Treatment Market Restraints
Table 22. Global Top Glaucoma Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Glaucoma Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Glaucoma Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Glaucoma Treatment, Headquarters and Area Served
Table 26. Global Glaucoma Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Glaucoma Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Glaucoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Glaucoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Glaucoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Glaucoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Glaucoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Glaucoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Glaucoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Glaucoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Glaucoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Glaucoma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Glaucoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Novartis Company Detail
Table 46. Novartis Business Overview
Table 47. Novartis Glaucoma Treatment Product
Table 48. Novartis Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 49. Novartis Recent Development
Table 50. Allergan Company Detail
Table 51. Allergan Business Overview
Table 52. Allergan Glaucoma Treatment Product
Table 53. Allergan Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 54. Allergan Recent Development
Table 55. Pfizer Company Detail
Table 56. Pfizer Business Overview
Table 57. Pfizer Glaucoma Treatment Product
Table 58. Pfizer Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 59. Pfizer Recent Development
Table 60. Akorn Company Detail
Table 61. Akorn Business Overview
Table 62. Akorn Glaucoma Treatment Product
Table 63. Akorn Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 64. Akorn Recent Development
Table 65. Teva Company Detail
Table 66. Teva Business Overview
Table 67. Teva Glaucoma Treatment Product
Table 68. Teva Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 69. Teva Recent Development
Table 70. Bausch & Lomb Company Detail
Table 71. Bausch & Lomb Business Overview
Table 72. Bausch & Lomb Glaucoma Treatment Product
Table 73. Bausch & Lomb Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 74. Bausch & Lomb Recent Development
Table 75. Otsuka Pharmaceutical Company Detail
Table 76. Otsuka Pharmaceutical Business Overview
Table 77. Otsuka Pharmaceutical Glaucoma Treatment Product
Table 78. Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 79. Otsuka Pharmaceutical Recent Development
Table 80. Santen Company Detail
Table 81. Santen Business Overview
Table 82. Santen Glaucoma Treatment Product
Table 83. Santen Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 84. Santen Recent Development
Table 85. Lunan Pharma Company Detail
Table 86. Lunan Pharma Business Overview
Table 87. Lunan Pharma Glaucoma Treatment Product
Table 88. Lunan Pharma Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 89. Lunan Pharma Recent Development
Table 90. Zizhu Pharma Company Detail
Table 91. Zizhu Pharma Business Overview
Table 92. Zizhu Pharma Glaucoma Treatment Product
Table 93. Zizhu Pharma Revenue in Glaucoma Treatment Business (2017-2022) & (US$ Million)
Table 94. Zizhu Pharma Recent Development
Table 95. Novartis Company Information
Table 96. Novartis Business Overview
Table 97. Novartis Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 98. Novartis Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 99. Novartis Recent Development
Table 100. Allergan Company Information
Table 101. Allergan Business Overview
Table 102. Allergan Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 103. Allergan Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 104. Allergan Recent Development
Table 105. Pfizer Company Information
Table 106. Pfizer Business Overview
Table 107. Pfizer Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 108. Pfizer Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 109. Pfizer Recent Development
Table 110. Akorn Company Information
Table 111. Akorn Business Overview
Table 112. Akorn Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 113. Akorn Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 114. Akorn Recent Development
Table 115. Teva Company Information
Table 116. Teva Business Overview
Table 117. Teva Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 118. Teva Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 119. Teva Recent Development
Table 120. Bausch & Lomb Company Information
Table 121. Bausch & Lomb Business Overview
Table 122. Bausch & Lomb Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 123. Bausch & Lomb Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bausch & Lomb Recent Development
Table 125. Otsuka Pharmaceutical Company Information
Table 126. Otsuka Pharmaceutical Business Overview
Table 127. Otsuka Pharmaceutical Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 128. Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 129. Otsuka Pharmaceutical Recent Development
Table 130. Santen Company Information
Table 131. Santen Business Overview
Table 132. Santen Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 133. Santen Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 134. Santen Recent Development
Table 135. Lunan Pharma Company Information
Table 136. Lunan Pharma Business Overview
Table 137. Lunan Pharma Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 138. Lunan Pharma Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 139. Lunan Pharma Recent Development
Table 140. Zizhu Pharma Company Information
Table 141. Zizhu Pharma Business Overview
Table 142. Zizhu Pharma Glaucoma Treatment Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million)
Table 143. Zizhu Pharma Revenue in Glaucoma Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 144. Zizhu Pharma Recent Development
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Glaucoma Treatment Product Picture
Figure 5. Global Glaucoma Treatment Market Size Comparison by Product (2023-2029) & (US$ Million)
Figure 6. Global Glaucoma Treatment Market Share by Product: 2022 VS 2029
Figure 7. Prostaglandin Analogs (PGAs) Product Picture
Figure 8. Beta Blocker Product Picture
Figure 9. Alpha Agonist Product Picture
Figure 10. Others Product Picture
Figure 11. Global Glaucoma Treatment Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Glaucoma Treatment Market Share by Application: 2022 VS 2029
Figure 13. Clinic Product Picture
Figure 14. Pharmacy Product Picture
Figure 15. Other Product Picture
Figure 16. Global Glaucoma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Glaucoma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Glaucoma Treatment Market Share by Region: 2022 VS 2029
Figure 19. Global Glaucoma Treatment Market Share by Players in 2022
Figure 20. Global Glaucoma Treatment Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Glaucoma Treatment Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Glaucoma Treatment Market Share by Country (2018-2029)
Figure 25. United States Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Glaucoma Treatment Market Share by Country (2018-2029)
Figure 29. Germany Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Glaucoma Treatment Market Share by Country (2018-2029)
Figure 37. China Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Glaucoma Treatment Market Share by Country (2018-2029)
Figure 45. Mexico Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Glaucoma Treatment Market Share by Country (2018-2029)
Figure 49. Turkey Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Glaucoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Novartis Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 53. Allergan Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 54. Pfizer Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 55. Akorn Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 56. Teva Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 57. Bausch & Lomb Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 58. Otsuka Pharmaceutical Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 59. Santen Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 60. Lunan Pharma Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)
Figure 61. Zizhu Pharma Revenue Growth Rate in Glaucoma Treatment Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings